FDA Adverse Event Malfunction Summary report: N

ARCHITECT C-PEPTIDE REAGENT

MDR report key: 2193631 · Received August 5, 2011

Report

Report Number
1415939-2011-00530
Event Type
Malfunction
Date Received
August 5, 2011
Date of Event
June 5, 2011
Report Date
June 17, 2011
Manufacturer
ABBOTT LABORATORIES
Product Code
JKD
PMA / PMN Number
EXEMPT
Removal / Correction Number
1415939-7/11/11-001-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EZ
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4): HIGH TEST RESULTS. THE CAUSE OF THE ARCHITECT C-PEPTIDE FALSELY ELEVATED QUALITY CONTROLS AND PATIENT RESULTS WAS DUE TO A NEW ANTIBODY LOT USED IN THE MANUFACTURING OF THE C-PEPTIDE MICROPARTICLE AND/OR CONJUGATE REAGENTS. ABBOTT ISSUED A PRODUCT RECALL LETTER TO ALL CUSTOMERS WITH INSTRUCTIONS TO DISCARD AND DESTROY ANY REMAINING INVENTORY OF THE AFFECTED LOTS.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED ELEVATED (B)(4) PROFICIENCY SAMPLE RESULT WHEN ARCHITECT C-PEPTIDE REAGENT LOT 017110A000 WAS IN USE. THE ABBOTT QUALITY CONTROLS WERE WITHIN SPECIFICATIONS, THEREFORE, THE CUSTOMER RECALIBRATED THE ASSAY AND ABBOTT CONTROLS WERE WITHIN SPECIFICATION, HOWEVER, THE EQA RESULTS REMAINED ELEVATED. THERE WAS NO IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT C-PEPTIDE REAGENT JKD ABBOTT LABORATORIES 01711A000

Patients

Seq Age Sex Outcome Treatment
1 (B)(4) SAMPLES| ARCHITECT I1000SR ANALYZER, LIST# 1L86-01